Company profile for Coave Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for r...
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
Nursery Paris Santé Cochin 27 rue du Faubourg Saint-Jacques 75014 Paris
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/14/3188181/0/en/Coave-Therapeutics-unveils-lead-gene-therapy-program-for-retinal-vascular-diseases-powered-by-first-in-class-vector-for-suprachoroidal-delivery.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/10/07/3162367/0/en/Coave-Therapeutics-demonstrates-superiority-of-its-novel-suprachoroidal-capsid-at-ESGCT-Congress-2025.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/05/21/3085540/0/en/Coave-Therapeutics-Establishes-New-Scientific-Advisory-Board-to-Accelerate-Innovation-in-Genetic-Medicines-for-Eye-and-CNS-Diseases.html

GLOBENEWSWIRE
21 May 2025

https://www.globenewswire.com/news-release/2025/05/09/3078543/0/en/Coave-Therapeutics-Launches-coAAV-CSF-01-a-Novel-CNS-Targeted-Gene-Therapy-Vector-for-Neurodegenerative-and-other-CNS-Diseases.html

GLOBENEWSWIRE
09 May 2025

https://www.globenewswire.com/news-release/2025/04/23/3066174/0/en/Coave-Therapeutics-Expands-into-the-US-with-Strategic-Appointment-of-Romain-Pettenaro-as-VP-of-Business-Development.html

GLOBENEWSWIRE
23 Apr 2025

https://www.globenewswire.com/news-release/2025/04/09/3058213/0/en/Coave-Therapeutics-to-Attend-Upcoming-Conferences.html

GLOBENEWSWIRE
09 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty